|
|
|
| home > white papers > Life Cycle of an Analytical Method - a Case Study on the Monocyte Activation Test - Wickham Laboratories Limited |
|
|
 WHITE PAPERS |
|
Wickham Laboratories Limited
|
|
Life Cycle of an Analytical Method - a Case Study on the Monocyte Activation Test
|
|
Pyrogens, a heterogeneous group of fever inducing contaminants, are comprised of microbial and non-microbial compounds; e.g. endotoxin (lipopolysaccharide, LPS) produced by Gram-negative bacteria, lipoteichoic acid (LTA) from Gram-positive bacteria, bacterial DNA (CpG-motive), endogenous pyrogens, virus and fungi particles or even fragments of packaging materials, plastic and dust. Contaminat ion wi th pyrogens in pharmaceutical products, biotherapeutics and on medical devices can lead to life threatening fever reactions. To ensure consumer safety, pyrogen testing is mandatory for parenteral products and medical devices.
|
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
Media Advisory AD Communications appointed PR Agency for PPMA
Please be advised that the PPMA Group of Associations has appointed AD Communications as PR agency with responsibility for its corporate and PPMA Show accounts.
More info >> |
|
 |
White Papers |
 |
|
Investigator Portals: Facilitating and Streamlining Communication & Collaboration with Study Sites
ArisGlobal
ArisGlobal LLC
Investigator site personnel are often frustrated with the lack of transparency and communication with their sponsors, leading to significant dissatisfaction and withdrawal from current and future studies. The adoption of investigator portals gives sponsors a platform that fosters collaboration and improves site management. Learn about five key areas of sponsor-investigator site interactions deserving of electronic communication and collaboration. Technology and design aspects are also covered.
More info >> |
|
 |
Industry Events |
 |
3rd PDA Europe Annual Meeting
26-27 June 2018, Berlin Marriott Hotel
The ongoing theme of the
European Annual Meeting is Global Healthcare of the Present & the Future,
as it intends to continue spanning a bridge between current demands within the
global healthcare industry, the amounting advanced technological and analytical
opportunities and the promising prospects personalized medicine and medicinal
products bring.
More info >> |
|
|
|
